🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)

RecruitingNAAges 6 Years - 18 YearsAllChina Medical University Hospital
NCT07364331 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. DSM-5 diagnosis of ADHD 2. Did not have any changes of ADHD treatment (pharmacological/psychological) within 4 weeks of entering the trial. 3. SNAP-IV inattention subscale \>=12, or hyperactivity subscale \>=12, or inattention+ hyperactivity subscales \>=24 Exclusion Criteria: 1. IQ\<80 2. Allergic to omega-3 3. Physical disorders: thyroid function, cancer 4. Psychiatric comorbidity: SUD, psychotic disorders, bipolar disorder, major depressive disorder
💊

What it tests

  • Omega-3
  • Placebo
📍

Where

1 site
China Medical University Hospital
Taichung, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy